Snowball logo
logo
6038_logo

Zhejiang Cheng Yi Pharmaceutical Co Ltd

603811 • SHG
¥6.87-¥0.09  (1.29%)
Estimate
P/E
17.2
EPS
0.4
Beta
0.072
Growth
Revenue, YoY
-0.12%
Net income, YoY
-24.09%
FCF, YoY
-10.11%
About the company
Ticker
603811
ISIN
CNE100002YC7
Country
China
Sector (GICS)
Healthcare
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, capsules, tablets, traditional Chinese medicines, preparations, and intermediates; and joint-related drugs, diuretics and antihypertensive drugs, antiviral drugs, antitumor drugs, vitamins, and sedative and brain-boosting drugs, as well as other health products and medical instruments. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

Frequently asked questions

What sector does Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) operate in?

Zhejiang Cheng Yi Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) current stock price?

As of the latest data, Zhejiang Cheng Yi Pharmaceutical Co Ltd stock price is CN¥6.87, with a previous close of CN¥6.96. Zhejiang Cheng Yi Pharmaceutical Co Ltd lost -CN¥0.09 in the last trading session, representing a -1.29% loss.

What is Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) current market capitalization?

Zhejiang Cheng Yi Pharmaceutical Co Ltd market cap is approximately 3.15 billion.

What is Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.40.

What is Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) Price-to-Earnings (P/E) ratio?

Zhejiang Cheng Yi Pharmaceutical Co Ltd current P/E ratio is 17.18.

Does Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) pay dividends?

No. Zhejiang Cheng Yi Pharmaceutical Co Ltd does not pay a dividend.

What is Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) beta (volatility) score?

Zhejiang Cheng Yi Pharmaceutical Co Ltd has a beta of 0.072, indicating lower volatility than the overall market.